Movatterモバイル変換


[0]ホーム

URL:


CN106119339A - A kind of stable, Serum Adenosine Deaminase detectable that capacity of resisting disturbance is strong and detection method - Google Patents

A kind of stable, Serum Adenosine Deaminase detectable that capacity of resisting disturbance is strong and detection method
Download PDF

Info

Publication number
CN106119339A
CN106119339ACN201610749595.XACN201610749595ACN106119339ACN 106119339 ACN106119339 ACN 106119339ACN 201610749595 ACN201610749595 ACN 201610749595ACN 106119339 ACN106119339 ACN 106119339A
Authority
CN
China
Prior art keywords
reagent
adenosine deaminase
detectable
serum
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610749595.XA
Other languages
Chinese (zh)
Inventor
李志明
甘宜梧
谭柏清
王珍
李贵雨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biobase Biodustry Shandong Co Ltd
Original Assignee
Biobase Biodustry Shandong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biobase Biodustry Shandong Co LtdfiledCriticalBiobase Biodustry Shandong Co Ltd
Priority to CN201610749595.XApriorityCriticalpatent/CN106119339A/en
Publication of CN106119339ApublicationCriticalpatent/CN106119339A/en
Pendinglegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The present invention relates to Serum Adenosine Deaminase detection technique field, particularly to a kind of Serum Adenosine Deaminase detectable, containing buffer in R1,4 amino ammonia replace pyrrole quinoline, PNP, XOD, POD, Bilirubin oxidase, ascorbic acid oxidase, glycerol, polyethylene glycol 6000, ethylene glycol, mannitol, trehalose, BSA, alkyl polyglucoside, preservative;Containing buffer in R2, adenosine, 3 hydroxyl 2,4,6 Triiodobenzoic acids, glycerol, polyethylene glycol 6000, ethylene glycol, mannitol, trehalose, BSA, alkyl polyglucoside, preservative;Use new Trinder to react chromogen substance 3 hydroxyl 2,4,6 Triiodobenzoic acid, add plurality of stable agent, significantly improve reagent stability;By adding Bilirubin oxidase, ascorbic acid oxidase and new non-ionic surfactants alkyl polyglucoside (APG), effectively prevent the interference of bilirubin and ascorbic acid, prevent reaction system muddy, substrate stability, the capacity of resisting disturbance of reagent all strengthen.

Description

A kind of stable, Serum Adenosine Deaminase detectable that capacity of resisting disturbance is strong and detectionMethod
Technical field
The present invention relates to Serum Adenosine Deaminase detection technique field, particularly to a kind of Serum Adenosine Deaminase detection examinationAgent, further relates to use the detection method of this detectable.
Background technology
ADA Adenosine deaminase (ADA) is the important enzyme in human body fast cry of certain animals nucleotide metabolism, is distributed widely in human body and respectively organizesIn, wherein the highest with content in thymus, spleen and other lymphoid tissues, and liver, lung, kidney and skeletal muscle equal size are relatively low;In serumADA essentially from liver, be the sensitive indicator of reflection hepatic injury, can be as one of liver function routine examination project, according to shouldEnzymatic activity increases or reduces reflection hepatocyte injury and recovery extent;Chronic hemolysis erythrocyte ADA activity is notable to be raised;SwollenIn tumor patients serum and tissue, ADA activity all raises;Patients with Tuberculous Meningitis CSF-ADA is significantly raised.
At present, the assay method of ADA Adenosine deaminase has Podbielniak development process, Ammonia Gas Sensor Electrode Method, enzyme process, enzyme coupling method etc.;RippleFamily name's development process reagent is simple, easily operated, but this method is easily affected by exogenous ammonium radical ion;Although Ammonia Gas Sensor Electrode Method is anti-dryAbility of disturbing is relatively strong, but is difficult to control to response signal and the response time of electrode, is unsuitable for the mensuration of clinical batch samples;Enzyme processSensitiveer, can realize automated analysis, but repeatability and accuracy are poor;Enzyme coupling method result is accurate, simple and practical, but is easily subject toThe material such as ascorbic acid and bilirubin disturbs.
In consideration of it, the present invention is on the basis of enzyme coupling method, optimizing reaction system, add Bilirubin oxidase and Vitamin CAcid oxidase, can be prevented effectively from the interference of bilirubin and ascorbic acid, is greatly enhanced the capacity of resisting disturbance of reagent, and usesNew Trinder reacts chromogen substance HTBA(3-hydroxyl-2,4,6-Triiodobenzoic acids), significantly enhance reagent stability andAccuracy;Additionally, by adding stabilizer, such as glycerol, polyethylene glycol 6000, mannitol, trehalose, BSA, ethylene glycol etc. canIt is effectively improved the stability of reagent;And the addition of preferred new non-ionic surfactants alkyl polyglucoside (APG) can prevent insteadAnswer system muddy, strengthen the stability of substrate, improve the capacity of resisting disturbance of reagent;This reagent operation is easy quickly, it is adaptable to fromDynamic fractional analysis, is a kind of more stable, Serum Adenosine Deaminase (ADA) reagent that capacity of resisting disturbance is strong.
Summary of the invention
It is an object of the invention to provide a kind of for detecting the reagent of Serum Adenosine Deaminase (ADA) and using this reagent to examineThe method surveying Serum Adenosine Deaminase activity.This test kit uses enzyme coupling method, can effectively detect Serum Adenosine DeaminaseActivity, the advantages such as capacity of resisting disturbance is strong, good stability.
Ultimate principle:
ADA(ADA Adenosine deaminase) catalytic substrate adenosine deamination generation inosine, inosine is again through PNP(purineNucleoside phosphorylase) effect generation hypoxanthine.Hypoxanthine is at XOD(xanthine oxidase) under effect, generate uric acid and mistakeHydrogen oxide (H2O2).Hydrogen peroxide (H2O2), can be with 3-hydroxyl-2 in the presence of peroxidase, 4,6-triiodo-benzenesFormic acid (HTBA) and 4-amino ammonia produce coloured awake compounds for pyrrole quinoline (4-AA) reaction, the generation speed of coloured awake compoundsRate and ADA(ADA Adenosine deaminase) activity relevant.By measuring the climbing speed of absorbance, the most coloured awake class at 550nm wavelengthCompound generating rate measures the activity of ADA Adenosine deaminase.
The present invention is obtained through the following steps:
A kind of Serum Adenosine Deaminase detectable, including reagent R1 and reagent R2, the composition of described reagent R1 and reagent R2 is such asUnder:
Reagent R1 contains
Buffer··························100mmol/L,
4-amino ammonia replaces pyrrole quinoline··················5mmol/L,
PNP(purine nucleoside phosphorylase)···········1.5KU/L,
XOD(xanthine oxidase)···············3.1KU/L,
POD(peroxidase)·················5KU/L,
Bilirubin oxidase····················3KU/L,
Ascorbic acid oxidase··················3.5KU/L,
Glycerol··························4ml/L,
Polyethylene glycol 6000····················5g/L,
Ethylene glycol··························6ml/L,
Mannitol··························25g/L,
Trehalose··························15g/L,
BSA·····························1g/L,
Alkyl polyglucoside (APG)···················1g/L,
Preservative··························0.5g/L;
2) component of reagent R2 is:
Buffer··························100mmol/L,
Adenosine····························14mmol/L,
HTBA(3-hydroxyl-2,4,6-Triiodobenzoic acid)···5mmol/L,
Glycerol··························4ml/L,
Polyethylene glycol 6000····················5g/L,
Ethylene glycol··························6ml/L,
Mannitol··························25g/L,
Trehalose··························15g/L,
BSA·····························1g/L,
Alkyl polyglucoside (APG)···················1g/L,
Preservative··························0.5g/L。
Described Serum Adenosine Deaminase detectable, in reagent R1, buffer is 25 DEG C, and pH is the HEPES buffering of 8.0Liquid.
Described Serum Adenosine Deaminase detectable, in reagent R2, buffer is 25 DEG C, and pH is the Tris buffering of 4.0Liquid.
Described Serum Adenosine Deaminase detectable, described preservative is NaN3.
Described Serum Adenosine Deaminase detectable detects the detection method of Serum Adenosine Deaminase content, uses completeAutomatic biochemistry analyzer utilizes performance rate method to be measured, and detection dominant wavelength is 550nm.
Described detection method, the ratio of R1 reagent and R2 reagent is 2:1.
Beneficial effects of the present invention:
1) add Bilirubin oxidase and ascorbic acid oxidase, the interference of bilirubin and ascorbic acid can be prevented effectively from, greatlyThe capacity of resisting disturbance of big Contrast agent;
2) new Trinder is used to react chromogen substance HTBA(3-hydroxyl-2,4,6-Triiodobenzoic acids), significantly enhance reagentStability and accuracy;
3) addition of new non-ionic surfactants alkyl polyglucoside (APG) can prevent reaction system muddy, strengthens the steady of substrateQualitative, improve the capacity of resisting disturbance of reagent;
4) optimizing reaction system to add glycerol, polyethylene glycol 6000, mannitol, trehalose, BSA, ethylene glycol etc. multiple surelyDetermine agent, the stability of reagent can be significantly improved;
5) accuracy of reagent and having good stability, strong interference immunity, easy to use, can meet clinical needs completely.
Accompanying drawing explanation
Fig. 1 is the correlation curve figure of two kinds of reagent,
Fig. 2 is two kinds of reagent effect phase stability curve figures,
Fig. 3 is embodiment 1 reagent test method,
Fig. 4 is that embodiment reagent interference free performance compares,
Fig. 5 is that embodiment 1 reagent Serum Adenosine Deaminase that is common with market and that get the nod measures test kit comparison and detection knotReally.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described.
Embodiment 1
The detectable of Serum Adenosine Deaminase, including reagent R1 and reagent R2:
1) the consisting of of its R1:
HEPES(4-hydroxyethyl piperazine ethanesulfonic acid) buffer (pH=8.0,25 DEG C)··100mmol/L,
4-amino ammonia replaces pyrrole quinoline·································5mmol/L,
PNP(purine nucleoside phosphorylase)··························1.5KU/L,
XOD(xanthine oxidase)······························3.1KU/L,
POD(peroxidase)································5KU/L,
Bilirubin oxidase···································3KU/L,
Ascorbic acid oxidase·································3.5KU/L,
Glycerol·········································4ml/L,
Polyethylene glycol 6000···································5g/L,
Ethylene glycol·········································6ml/L,
Mannitol·········································25g/L,
Trehalose·········································15g/L,
BSA············································1g/L,
Alkyl polyglucoside (APG)··································1g/L,
Liquid BPF aN3·····································0.5g/L;
2) component of reagent R2 is:
Tris(trishydroxymethylaminomethane) buffer (pH=4.0,25 DEG C)·····100mmol/L,
Adenosine···········································14mmol/L,
HTBA(3-hydroxyl-2,4,6-Triiodobenzoic acid)··················5mmol/L,
Glycerol·········································4ml/L,
Polyethylene glycol 6000···································5g/L,
Ethylene glycol·········································6ml/L,
Mannitol·········································25g/L,
Trehalose·········································15g/L,
BSA············································1g/L,
Alkyl polyglucoside (APG)··································1g/L,
Liquid BPF aN3·····································0.5g/L;
3) using method of the present embodiment reagent:
The Serum Adenosine Deaminase detectable that the present embodiment describes, uses in use and has the full-automatic raw of double reagent functionFractional analysis instrument, such as Hitachi 7180 fully-automatic analyzer etc., utilizes performance rate method to be measured;R1 and R2 is put according to the ratio of 2:1Putting on the reagent position of correspondence, the correspondence position at specimen disc places distilled water, standard substance and sample, and operation is such as Fig. 3.
Embodiment 2
Interference is tested: takes fresh mix serum, is divided into 2 equal portions, then every equal portions is separated into 5 equal portions, adds different doingDisturb material so that it is the concentration in serum reaches the requirement of Fig. 4;The most respectively with embodiment 1 gained reagent, common with market alsoThe activity of ADA, matched group measurement result and addition in Serum Adenosine Deaminase (ADA) reagent of accreditation comparative determination serum simultaneouslyAfter disturbance material, the measurement result of each group is shown in Fig. 4;Relative deviation (%)=(mensuration average-check sample of interference sampleMensuration average) mensuration average × 100% of/check sample;
As seen from Figure 4, embodiment 1 reagent is in total bilirubin≤30mg/dL, triglyceride≤3000mg/dL, hemoglobinWhen≤800mg/dL, ascorbic acid≤220mg/dL, test result is not substantially interfered with, and matched group reagent is in above-mentioned concentrationIn the presence of interfering material, being substantially interfered with, this explanation is by optimizing reaction buffer system, Bilirubin oxidase and ascorbic acidAfter oxidase, and new non-ionic surfactants alkyl polyglucoside (APG), the interference free performance of embodiment 1 reagent significantly improves,It is far superior to contrast agent.
Embodiment 3
Dependency is tested: utilize embodiment 1 formula reagent preparation, the State Food and Drug Administration accreditation common with marketADA Adenosine deaminase (ADA) test kit of certain company carry out control test, have detected 20 clinical serum samples, detection knot simultaneouslyFruit as it is shown in figure 5, and obtain the correlation curve (as shown in Figure 1) of two kinds of reagent, shown by testing result, two reagentThe correlation coefficient of box is 0.9996, illustrates that both have great dependency.
Embodiment 4
The stability contrast test of reagent: to the reagent in embodiment 1, uniform subpackage 13 groups, amount of reagent R1 often organized is 20mL,R2 is 10mL;And take the ADA Adenosine deaminase of certain company of 13 groups of common State Food and Drug Administration's accreditations in market(ADA) test kit compares;It is placed in 2-8 DEG C of refrigerator, taking-up on the same day group reagent detection ADA quality-control product (target monthlyValue is for 35.7U/L), testing result is as in figure 2 it is shown, the adenosine more common than market under 2-8 DEG C of condition of storage of embodiment 1 reagent takes offIt is more stable that ammonia enzyme (ADA) measures test kit;
By checking, this reagent is good with similar detectable contrast dependency, and Clinical detection sample results is consistent, it is possible to reach cityThe field application requirement to product, and good in anti-interference performance, be a kind of more stable, good ADA Adenosine deaminase (ADA) detectionReagent.

Claims (7)

CN201610749595.XA2016-08-292016-08-29A kind of stable, Serum Adenosine Deaminase detectable that capacity of resisting disturbance is strong and detection methodPendingCN106119339A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
CN201610749595.XACN106119339A (en)2016-08-292016-08-29A kind of stable, Serum Adenosine Deaminase detectable that capacity of resisting disturbance is strong and detection method

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
CN201610749595.XACN106119339A (en)2016-08-292016-08-29A kind of stable, Serum Adenosine Deaminase detectable that capacity of resisting disturbance is strong and detection method

Publications (1)

Publication NumberPublication Date
CN106119339Atrue CN106119339A (en)2016-11-16

Family

ID=57273601

Family Applications (1)

Application NumberTitlePriority DateFiling Date
CN201610749595.XAPendingCN106119339A (en)2016-08-292016-08-29A kind of stable, Serum Adenosine Deaminase detectable that capacity of resisting disturbance is strong and detection method

Country Status (1)

CountryLink
CN (1)CN106119339A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN108169152A (en)*2017-12-272018-06-15山东博科生物产业有限公司A kind of angiotensin converting enzyme detection kit and its application method
CN112611727A (en)*2020-11-272021-04-06江西乐成生物医疗有限公司Glutathione transferase detection kit, preparation method and application
CN112710854A (en)*2021-01-082021-04-27中拓生物有限公司Anti-interference and stable serum total bilirubin (enzyme method) determination kit and preparation method and application thereof
CN112710853A (en)*2021-01-082021-04-27中拓生物有限公司Anti-interference and stable serum direct bilirubin (enzyme method) determination kit and preparation method and application thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN102175670A (en)*2010-12-302011-09-07北京九强生物技术股份有限公司Method for detecting 1,5-dehydration glucitol in blood and kit
CN103320498A (en)*2013-05-242013-09-25宁波美康生物科技股份有限公司Detection reagent for aspartate aminotransferase
CN103320497A (en)*2013-05-242013-09-25宁波美康生物科技股份有限公司Detection reagent for alanine aminotransferase
CN105238847A (en)*2015-09-162016-01-13山东博科生物产业有限公司Stable adenosine deaminase reagent high in anti-interference capability and detection method
CN105420344A (en)*2015-12-122016-03-23山东博科生物产业有限公司Stable serum-potassium detection reagent with high anti-interference capability and detection method
CN105420345A (en)*2015-12-162016-03-23山东博科生物产业有限公司Stable serum 5'-ribotide hydrolase detection reagent with strong anti-interference capability and detection method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN102175670A (en)*2010-12-302011-09-07北京九强生物技术股份有限公司Method for detecting 1,5-dehydration glucitol in blood and kit
CN103320498A (en)*2013-05-242013-09-25宁波美康生物科技股份有限公司Detection reagent for aspartate aminotransferase
CN103320497A (en)*2013-05-242013-09-25宁波美康生物科技股份有限公司Detection reagent for alanine aminotransferase
CN105238847A (en)*2015-09-162016-01-13山东博科生物产业有限公司Stable adenosine deaminase reagent high in anti-interference capability and detection method
CN105420344A (en)*2015-12-122016-03-23山东博科生物产业有限公司Stable serum-potassium detection reagent with high anti-interference capability and detection method
CN105420345A (en)*2015-12-162016-03-23山东博科生物产业有限公司Stable serum 5'-ribotide hydrolase detection reagent with strong anti-interference capability and detection method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
钟如良等: "61例肺结核影像学表现及血清腺苷脱氨酶检测", 《现代生物医学进展》*

Cited By (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN108169152A (en)*2017-12-272018-06-15山东博科生物产业有限公司A kind of angiotensin converting enzyme detection kit and its application method
CN112611727A (en)*2020-11-272021-04-06江西乐成生物医疗有限公司Glutathione transferase detection kit, preparation method and application
CN112710854A (en)*2021-01-082021-04-27中拓生物有限公司Anti-interference and stable serum total bilirubin (enzyme method) determination kit and preparation method and application thereof
CN112710853A (en)*2021-01-082021-04-27中拓生物有限公司Anti-interference and stable serum direct bilirubin (enzyme method) determination kit and preparation method and application thereof
CN112710853B (en)*2021-01-082021-11-02中拓生物有限公司Anti-interference and stable serum direct bilirubin (enzyme method) determination kit and preparation method and application thereof
CN112710854B (en)*2021-01-082021-11-23中拓生物有限公司Anti-interference and stable serum total bilirubin (enzyme method) determination kit and preparation method and application thereof

Similar Documents

PublicationPublication DateTitle
CN105543336B (en)A kind of stabilization, the serum phospholipids detection reagent of strong antijamming capability and detection method
CN106119339A (en)A kind of stable, Serum Adenosine Deaminase detectable that capacity of resisting disturbance is strong and detection method
CN106868096B (en)High-stability and low-cost glucose detection reagent by hexokinase method
CN109991177A (en)A kind of stabilization, bilirubin direct (enzymatic measurement) detection reagent of strong antijamming capability and detection method
CN104198407A (en)Detection kit for detecting content of beta-hydroxybutyrate in serum by adopting stable enzymatic method
CN105420345A (en)Stable serum 5'-ribotide hydrolase detection reagent with strong anti-interference capability and detection method
CN104931448B (en)A kind of detection reagent and its detection method of lactate dehydrogenase isoenzyme 1
CN107641642A (en)A kind of creatine kinase isozyme double reagent and preparation method thereof
CN103773833A (en)Creatinine measurement reagent
CN107525936A (en)The composition of troponin antibodies stability in a kind of lifting latex immunoturbidimetry
CN101464299A (en)Kalium ion diagnosis/measuring reagent kit and kalium ion concentration determination method
CN112710853A (en)Anti-interference and stable serum direct bilirubin (enzyme method) determination kit and preparation method and application thereof
CN103397076B (en)The application in the biochemical reagents of negative value or null value is there is in chlorate in preparation elimination measurement result
CN102866197A (en)Method for quickly detecting concentrations of various electrolytes by ion-selective electrodes
CN103558398A (en)Anti-heparan-interference ischemia modified albumin detection reagent
CN106884034A (en)A kind of stabilization, 5 '-ribonucleotide hydrolytic enzyme detection reagent of strong antijamming capability and detection method
CN101750354A (en)Adenosine deaminase diagnostic reagent (kit) and adenosine deaminase activity concentration measuring method
CN101464406A (en)Kalium ion diagnosis/measuring reagent kit and kalium ion concentration determination method
CN101750355A (en)Adenosine deaminase diagnostic reagent (kit) and adenosine deaminase activity concentration measuring method
CN101173930A (en)Sodium diagnosis/measuring reagent kit and method for measuring sodium concentration
CN106544400A (en)A kind of glucose 6 phosphate dehydrogenase enzyme detection kit of suitable automatic clinical chemistry analyzer
CN106556595A (en)A kind of Picric kinetic method detection kit of strong antijamming capability
CN101750382A (en)Diagnostic reagent (kit) of adenosine deaminase and method for measuring activity concentration of adenosine deaminase
CN115078341A (en)Reagent for detecting glucose-6-phosphate dehydrogenase and application thereof
CN101620167A (en)Adenosine deaminase diagnosis kit and method for determining adenosine deaminase activity concentration

Legal Events

DateCodeTitleDescription
C06Publication
PB01Publication
C10Entry into substantive examination
SE01Entry into force of request for substantive examination
RJ01Rejection of invention patent application after publication

Application publication date:20161116

RJ01Rejection of invention patent application after publication

[8]ページ先頭

©2009-2025 Movatter.jp